» Articles » PMID: 38726188

MicroRNAs As the Critical Regulators of Epithelial Mesenchymal Transition in Pancreatic Tumor Cells

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 May 10
PMID 38726188
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer (PC), as one of the main endocrine and digestive systems malignancies has the highest cancer related mortality in the world. Lack of the evident clinical symptoms and appropriate diagnostic markers in the early stages of tumor progression are the main reasons of the high mortality rate among PC patients. Therefore, it is necessary to investigate the molecular pathways involved in the PC progression, in order to introduce novel early diagnostic methods. Epithelial mesenchymal transition (EMT) is a critical cellular process associated with pancreatic tumor cells invasion and distant metastasis. MicroRNAs (miRNAs) are also important regulators of EMT process. In the present review, we discussed the role of miRNAs in regulation of EMT process during PC progression. It has been reported that the miRNAs mainly regulate the EMT process in pancreatic tumor cells through the regulation of EMT-specific transcription factors and several signaling pathways such as WNT, NOTCH, TGF-β, JAK/STAT, and PI3K/AKT. Considering the high stability of miRNAs in body fluids and their role in regulation of EMT process, they can be introduced as the non-invasive diagnostic markers in the early stages of malignant pancreatic tumors. This review paves the way to introduce a non-invasive EMT based panel marker for the early tumor detection among PC patients.

Citing Articles

Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease.

Rahman M, Ghorai S, Panda K, Santiago M, Aggarwal S, Wang T Noncoding RNA Res. 2024; 11:22-37.

PMID: 39736851 PMC: 11683234. DOI: 10.1016/j.ncrna.2024.11.001.

References
1.
Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

2.
Paulson A, Tran Cao H, Tempero M, Lowy A . Therapeutic advances in pancreatic cancer. Gastroenterology. 2013; 144(6):1316-26. DOI: 10.1053/j.gastro.2013.01.078. View

3.
Kong L, Liu P, Zheng M, Wang Z, Gao Y, Liang K . The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways. Onco Targets Ther. 2020; 13:3449-3466. PMC: 7185335. DOI: 10.2147/OTT.S248507. View

4.
Bivik C, MacDonald R, Gunnar E, Mazouni K, Schweisguth F, Thor S . Control of Neural Daughter Cell Proliferation by Multi-level Notch/Su(H)/E(spl)-HLH Signaling. PLoS Genet. 2016; 12(4):e1005984. PMC: 4829154. DOI: 10.1371/journal.pgen.1005984. View

5.
Li G, Kanagasabai T, Lu W, Zou M, Zhang S, Celada S . KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis. Cancer Res. 2020; 80(21):4633-4643. PMC: 8034842. DOI: 10.1158/0008-5472.CAN-20-0505. View